Fetal and neonatal therapies improve prognosis of congenital cytomegalovirus infection
Vaccine wars escalate as new antibody escape variants raise the bar
28 January 2021Using artificial intelligence to predict which women will develop breast cancer
28 January 2021Fetal and neonatal therapies improve prognosis of congenital cytomegalovirus infection
A cross-institutional research group has revealed for the first time in the world that infants with symptomatic congenital cytomegalovirus (CMV) infection who were treated with a combination of immunoglobulin fetal therapy and neonatal therapy with antiviral drugs were less likely to experience the severe aftereffects associated with the infection than those who only received the neonatal therapy.
